Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The DESTINY Trial: a Prospective Randomized Multicenter Trial Comparing the Implant of a Drug Eluting Stent (XIENCE V, Abbott Vascular) vs. a Bare Metal Stent (MULTILINK VISION, Abbott Vascular) in the Critically Ischemic Lower Leg

NCT00510393 is registered in ClinicalTrials.gov with Flanders Medical Research Program as lead sponsor.

NCT NCT00510393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00510393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The DESTINY Trial: a Prospective Randomized Multicenter Trial Comparing the Implant of a Drug Eluting Stent (XIENCE V, Abbott Vascular) vs. a Bare Metal Stent (MULTILINK VISION, Abbott Vascular) in the Critically Ischemic Lower Leg
Lead sponsor
Flanders Medical Research Program
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
November 30, 2010
Enrollment
140 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral vascular disease